|Articles|October 4, 2019

The Augmented Psychiatrist: How Technology Will Transform Mental Health Clinical Practice

Key Takeaways

  • Objective digital phenotyping from wearables and smartphones is expected to supplement clinical interviews with longitudinal, quantitative signals relevant to assessment and monitoring.
  • Digital tools can operationalize adherence support, scalable access pathways, and earlier detection/intervention workflows, potentially shifting care upstream and reducing reliance on episodic visits.
SHOW MORE

Excitement in digital health is growing due to rapid advances in artificial intelligence, data science, and smart devices. How will the growing number of mental health technologies impact clinical practice? Arshya Vahabzadeh, MD provides insights.

Excitement in digital health is growing due to rapid advances in artificial intelligence, data science, and smart devices. How will the growing number of mental health technologies impact clinical practice? Arshya Vahabzadeh, MD provides insights in this video.

The augmented psychiatrist of the near future will use these evidence-based tools to i) assess patients using objective and quantitative data from smart devices, ii) use digital aids to improve patient adherence, access, and early intervention, and iii) be able to recommend prescription digital therapeutics that target behavioral health conditions.

Dr Vahabzadeh is on the faculty at Massachusetts General Hospital; Innovation Officer at the Massachusetts General Hospital Psychiatry Academy; and the Chief Medical Officer of Brain Power LLC, Cambridge, MA. He has served on the MIT Solve Brain Leadership Group and on the faculty at Harvard Medical School. Dr Vahabzadehis spoke at the 2019 Psych Congress® in San Diego, CA, in a presentation titled “Future Psychiatry: A Technological and Neuroscientific Convergence.”

Dr Vahabzadeh reports that he has commercial interest in and receives compensation for his work with Brain Power LLC.

The articles and interviews featured on this page were developed by Psychiatric Times editorial staff and contributors based on presentations delivered at Psych Congress®, an annual conference produced by HMP Global, LLC. Psychiatric Times is an independent publication and is not affiliated with, endorsed by, or sponsored by HMP Global, LLC. All content on this page reflects the independent editorial judgment of Psychiatric Times and does not represent the views, positions, or communications of HMP Global, LLC.